Home
Products
AI EPIC Co-Ablation System
EXCEED Microwave Ablation Device
Resources
Clinical Cases
Lung Cancer
Bone Cancer
Liver Cancer
Pancreas Cancer
Publications
Videos
About Hygea
Company Profile
News & Events
Company News
Contact
CN
En
EN
Search
>
EN
En
Search
Home
Products
AI EPIC Co-Ablation System
EXCEED Microwave Ablation Device
Resources
Clinical Cases
Publications
Videos
About Hygea
Company Profile
News & Events
Company News
Contact
Home
Products
AI EPIC Co-Ablation System
EXCEED Microwave Ablation Device
Resources
Clinical Cases
Lung Cancer
Bone Cancer
Liver Cancer
Pancreas Cancer
Publications
Expert Consensus on Clinical Practice of Percutaneous Cold and Hot Multi-modal Ablation for Treatment of Pulmonary Malignant Tumor
Expert Consensus on Clinical Practice of Multi-model Cold and Hot Ablation for Treatment of Liver Malignant Tumors
Efficacy and Safety of CT-guided Percutaneous Combined Cryoablation for Malignant Lung Tumors
Expert Consensus on Clinical Practice of Multi-Model Ablation for Treatment of Liver Malignant Tumors
Expert Consensus on Clinical Practice of Percutaneous Multi-Modal Cold and Hot Ablation for Treatment of Pulmonary Malignant Tumor
Health Technology Assessment of A New Generation of Domestic Cryosurgical System
Research of Cryotherapy
Short-Term Efficacy and Safety of Ct-Guided Percutaneous Compound Cryoablation for Liver Malignancies
The Clinical and Experimental Study of Ablation Therapy Combined with Chemotherapy or Chemotherapy Alone in the Treatment of Stage IV Pancreatic Cancer
The Clinical Study of Intraoperative Cryoablation Therapy and Intraoperative Combined Cryoablation and Hyperthermia in the Treatment of Unresectable Pancreatic Cancer
Cryoablation plus sintilimab and Lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial
Ablation Plus Continuous Anti–PD-1/PD-L1 Therapy in Advanced NSCLC With Oligo-Residual Disease: The BOOSTER Randomized Phase II Trial
Videos
Introduction of HYGEA Co-Ablation System
Co-Ablation System: New Generation of Cryoablation
Co-Ablation Application on Breast Cancer Surgery
Co-Ablation Application on Breast Cancer Surgery
AI Epic™ Co-Abaltion System
About Hygea
Company Profile
News & Events
Company News
Minimally Invasive Ablation Leading the Future — Hygea Showcases Two Flagship Products at CIRSE 2025
Hygea and SHAHCO Sign Landmark MoU for Cancer Care in Pakistan, Witnessed by the Prime Minister of Pakistan
ISMIO 2025: Hygea Symposium Unites Nations on Cutting-Edge Tumor Ablation Techniques
China - Morocco Cooperation and Exchange in Ablation Techniques of Minimally Invasive Tumor Treatment
New China-Pakistan cooperation progression, Punjab Province Pakistan signing a memorandum of understanding on cooperation with Hygea Medical
Co-Ablation System’s first commercial use in Turkey has been successfully completed!
Great news! BETTER AND BETTER | After NMPA approval, HYGEA's microwave ablation system for minimally invasive tumor treatment now also FDA-approved!
「BEST」ABLATION &「FIRST」 SHOW UP at「MEDICA」
Show in the ARAB HEALTH
How Effective is Cryoablation Device for Kidney Cancer?
Comprehensive Training And Certification Process For Cryoablation System Utilization
Contrasting Technologies In Tumor Ablation: Cryosurgical System Vs. Microwave Ablation
Precision Planning in Cryotherapy for Liver Cancer
Advantages Of Cryosurgical System For Lung Cancer
Minimally Invasive Techniques for Liver Cancer: The Role of Cryotherapy
Comparison Results of Cryotherapy and Traditional Lung Metastasis Therapy
Clinical Application and Advantages of Cryoablation for Bone Cancer
Advantages and Research of Cryoablation Pancreatic Cancer
Cryotherapy for Lungs in the Treatment of Lung Cancer
Hygea Medical shows up at MEDICA 2024, state-of-the-art medical technology shining on the international arena
China-Caribbean Seminar on Minimally Invasive Oncology Technologies Successfully Concluded at Hygea Medical
Clinical Evidence: Cryoablation Empowering Immunotherapy in Advanced Cholangiocarcinoma
The first randomized phase II trial evaluating ablation plus immunotherapy in advanced NSCLC with oligo-residual disease
Hygea Co-Ablation System for Lung Tumors: Clinical Evidence from a Large Retrospective Study
Contact
Email Us
Contact
Home
Contact
Email
overseas@hygeamed.com
Phone
010-82158025
Head Office Address
No. 1, Science Park, Beijing Satellite Factory, 63 Zhichun Road, Haidian District, Beijing, China
Thanks For Your Inquiry
Submit
Hygea Medical Latest News
Company News
Hygea Co-Ablation System for Lung Tumors: Clinical Evidence from a Large Retrospective Study
Company News
Nov 20,2025
The first randomized phase II trial evaluating ablation plus immunotherapy in advanced NSCLC with oligo-residual disease
Company News
Nov 05,2025
Clinical Evidence: Cryoablation Empowering Immunotherapy in Advanced Cholangiocarcinoma
Clinical Cases
Lung Cancer
Bone Cancer
Liver Cancer
Pancreas Cancer
Quick Links
AI EPIC Co-Ablation System
Company Profile
Company News
Contact
Email:
overseas@hygeamed.com
Tel:
010-82158025
Head Office Address: No. 1, Science Park, Beijing Satellite Factory, 63 Zhichun Road, Haidian District, Beijing, China
Copyright ©
Hygea Medical Technology Co., Ltd.
All Rights Reserved.
Sitemap
|
Privacy Policy
overseas@hygeamed.com
Contact Us
010-82158025
Latest News
Back Top
Your browser does not support VBScript!
EN 
